Title: Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Journal: Journal of medicinal chemistry 20131114
Title: Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.
Journal: Pharmacological research 20120901
Title: Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats.
Journal: British journal of pharmacology 20120701
Title: NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201
Title: Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.
Journal: Journal of medicinal chemistry 20111222
Title: Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
Journal: Journal of medicinal chemistry 20110728
Title: Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.
Journal: Prostaglandins & other lipid mediators 20110201
Title: BDNF regulates neuronal sensitivity to endocannabinoids.
Journal: Neuroscience letters 20091225
Title: CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.
Journal: Neurochemistry international 20081201
Title: Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.
Journal: Neurochemistry international 20080101
Title: The orphan receptor GPR55 is a novel cannabinoid receptor.
Journal: British journal of pharmacology 20071201
Title: Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Journal: British journal of pharmacology 20071101
Title: 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling.
Journal: European journal of pharmacology 20070322
Title: Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Journal: British journal of pharmacology 20070301
Title: Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
Journal: Bioorganic & medicinal chemistry 20070115
Title: Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.
Journal: Analytical biochemistry 20070115
Title: Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility.
Journal: Investigative ophthalmology & visual science 20060501
Title: Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
Journal: The Journal of physiology 20051201
Title: Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20051101
Title: Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect?
Journal: Neurochemical research 20051001
Title: Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20050915
Title: Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
Journal: Behavioural pharmacology 20050901
Title: The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Journal: Journal of medicinal chemistry 20050811
Title: The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20050801
Title: Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus.
Journal: Experimental neurology 20050701
Title: Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice.
Journal: Brain research bulletin 20050315
Title: Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
Journal: British journal of pharmacology 20040601
Title: Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Journal: Molecular pharmacology 20040301
Title: Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species.
Journal: Journal of neurochemistry 20030601
Title: Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors.
Journal: Bioorganic & medicinal chemistry letters 20030106
Title: Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Journal: Neuroscience letters 20021031
Title: Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
Journal: Investigative ophthalmology & visual science 20021001
Title: Acute neuronal injury, excitotoxicity, and the endocannabinoid system.
Journal: Molecular neurobiology 20020101
